Qatar is one of the wealthiest nations per capita in the world, with a GDP exceeding $220 billion and a population of approximately 3 million — of which roughly 85% are expatriates. The country's Qatar National Vision 2030 (QNV 2030) is driving economic diversification, healthcare investment, and consumer market growth that creates significant demand for rigorous market research.
The pharmaceutical market in Qatar is valued at approximately $1.2 billion and growing steadily, supported by the Supreme Council of Health's (SCH/MoPH) national health strategy and significant investment in Hamad Medical Corporation (HMC) and Sidra Medicine. Research buyers in Qatar need partners familiar with the Ministry of Public Health (MoPH) regulatory framework and the Qatar Pharmaceutical Manufacturing Company landscape.
For consumer research, Qatar's highly international demographic profile — with expatriate communities from South Asia, MENA, and the West — requires sophisticated multilingual sampling and demographic segmentation. Luxury, FMCG, financial services, and digital economy research are all growing categories. The right market research partner must combine global methodology standards with local Qatar execution capability and Arabic-English bilingual delivery.